CGAS and malignant colon neoplasm: To further validate whether lovastatin enhances sensitivity to radiotherapy in a colon cancer xenograft model through the activation of cGAS–STING in vivo, we detected a substantial increase in the expression of genes associated with the cGAS–STING signaling pathway in the combination therapy group compared with the radiotherapy group (Fig. 7c).